Sort
48,018 grants matching “immunotherapy”
Targeting the IL-2/regulatory T cell axis for autoimmune disease prevention in realistic animal models
$679,264Daniel J. Campbell · Benaroya Research Inst At Virginia Mason · R01 · FY2020 · AI
Targeting the IL-2/regulatory T cell axis for autoimmune disease prevention in realistic animal models
$679,264Daniel J. Campbell · Benaroya Research Inst At Virginia Mason · R01 · FY2022 · AI
Targeting the IL-2/regulatory T cell axis for autoimmune disease prevention in realistic animal models
$679,264Daniel J. Campbell · Benaroya Research Inst At Virginia Mason · R01 · FY2021 · AI
A network approach to interrogate cellular plasticity and drug resistance in cancer
$679,232Rosemary J Akhurst · University Of California, San Francisco · R01 · FY2025 · CA
Pathobiology of ANCA Glomerulonephritis: Targeting Adaptive and Innate Immune Processes for Precision Therapies
$679,218Ronald J Falk · Univ Of North Carolina Chapel Hill · R01 · FY2022 · DK
ALLOGENEIC TGF-B ANTISENSE CELL VACCINE FOR LUNG CANCER
$679,195Novarx Corporation · R44 · FY2003 · CA
Immunoregulatory role of lung-resident club cell factors in lung cancer
$679,154Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Immunoregulatory role of lung-resident club cell factors in lung cancer
$679,154Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Adaptive epigenetic mechanisms of beta and immune cells in autoimmune diabetes
$679,061Kevan C Herold · Yale University · R01 · FY2022 · DK
Development of Physiologic Tissue Models to Assess Tumor Explant Response to Immune Checkpoint Blockade
$678,954Roger D. Kamm · Massachusetts Institute Of Technology · U01 · FY2019 · CA
bZIP proteins, NFAT, and lymphocyte gene induction
$678,945Anjana Rao · La Jolla Institute For Immunology · R01 · FY2014 · AI
Frequency and phenotype of Fel d 1-specific T cells after peptide therapy
$678,916Mark Larche · Mcmaster University · U19 · FY2012 · AI
Pathobiology of ANCA Glomerulonephritis: Targeting Adaptive and Innate Immune Processes for Precision Therapies
$678,823Ronald J Falk · Univ Of North Carolina Chapel Hill · R01 · FY2020 · DK
Career Development in Pediatric and Medical Oncology
$678,791Irwin Bernstein · Fred Hutchinson Cancer Research Center · K12 · FY2019 · CA
Identifying cellular and molecular signatures from distinct T cell receptor clonotypes associated with favorable immune checkpoint inhibitor responses in HNSCCs
$678,731Robert L Ferris · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DE
Regulation of memory T cell differentiation and long-term maintenance
$678,728Ananda W Goldrath · University Of Florida · P01 · FY2024 · AI
PD-L1 MODIFICATIONS IN CANCER DIAGNOSIS AND TREATMENT
$678,723Yong Li · Baylor College Of Medicine · R01 · FY2025 · CA
Prostate Cancer Immunotherapy
$678,709Rockefeller University · R01 · FY2004 · CA
Proteolysis targeting chimera against nuclear receptor NR4A1 for melanoma therapy
$678,605Weizhou Zhang · University Of Florida · R01 · FY2024 · CA
Cancer Chemotherapy Training Program
$678,580Dean F. Bajorin · Sloan-Kettering Inst Can Research · T32 · FY2006 · CA
TARGETING PCD FOR CANCER THERAPY
$678,476University Of Michigan At Ann Arbor · P01 · FY2000 · CA
Biogenic Gas Nanostructures as Molecular Imaging Reporters for Ultrasound
$678,465Mikhail Shapiro · California Institute Of Technology · R01 · FY2024 · EB
Chromatin and transcriptional regulatory factors that initiate and stabilize memory CD8 T cell development
$678,426Matthew Eugene Pipkin · University Of Florida · P01 · FY2023 · AI
Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer
$678,424Moran Amit · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · DE
Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer
$678,424Moran Amit · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · DE